1-9 of 9
Jose Francisco Falantes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Graft Versus Host Disease Prophylaxis with Tacrolimus, Sirolimus and MMF in Patients Undergoing Reduced Intensity Conditioning Allogeneic Transplantation

Lucia Lopez Corral, Cristina Blázquez Goñi, Estefanía Pérez López, Francisco Manuel Martín Domínguez, Almudena Cabero Martínez, Nancy Rodríguez Torres, Monica Cabrero Calvo, Ildefonso Espigado, Ana Africa Martin Lopez, Rocio Parody, Mónica Baile González, Teresa Caballero, María Cortés-Rodríguez, Elena Soria Saldise, Alejandro Avendaño Pita, Patricia Alcalde Mellado, Ana García Bacelar, Eduardo Rodriguez Arboli, Miriam Lopez Parra, Jose Francisco Falantes, Almudena Navarro Bailon, Lourdes Vázquez López, Virginia Escamilla Gomez, Fermin Sanchez-Guijo Martin, Jose A. Pérez-Simón
Journal: Blood
Blood (2023) 142 (Supplement 1): 4933.
https://doi.org/10.1182/blood-2023-185757
Published: 2023
Journal Articles

Data-Driven Multiparameter Flow Cytometry (MFC) Classification of Blast Differentiation in Elderly Patients with Acute Myeloid Leukemia (AML)

Carmen Gonzalez, Catia Simoes, Beñat Ariceta, David Martinez-Cuadron, Juan Miguel Bergua Burgues, Susana Vives, Lorenzo Algarra, Mar Tormo, Pilar Martinez Sanchez, Josefina Serrano, Pilar Herrera, Fernando Ramos, Olga Salamero, Esperanza Lavilla, Cristina Gil, Jose Luiz Lopez Lorenzo, Maria Vidriales Vicente, Carmen Chillon, Jorge Labrador, Jose Francisco Falantes, Maria Jose Sayas Lloris, Rosa Ayala, Joaquin Martinez-Lopez, Sara Villar, Maria Jose Calasanz, Felipe Prosper, Jesus San Miguel, Miguel A. Sanz, Pau Montesinos, Bruno Paiva
Journal: Blood
Blood (2023) 142 (Supplement 1): 1571.
https://doi.org/10.1182/blood-2023-180646
Published: 2023
Journal Articles

Chronic Myelomonocytic Leukemia (CMML) with AML Typical Mutations ( NPM1, FLT3 or CEBPA ) Identify a High-Risk CMML Group Independent of Molecular-Cpss

Sandra Castaño-Díez, Ines Zugasti, Xavier Calvo, Felicitas Schulz, Alejandro Avendaño Pita, Elvira Mora, Jose Francisco Falantes, Gemma Azaceta, Mariam Ibáñez, Tzu Chen, Cristina Notario, Neus Amer Salas, Mònica López-Guerra, Carlos Jimenez-Vicente, Daniel Esteban, Francesca Guijarro, José Ramón Álamo Moreno, Albert Cortés-Bullich, Daniel Munárriz, Víctor Torrecillas-Mayayo, Ana Triguero, Natalia Tovar, Alexandra Martínez-Roca, Beatriz Merchán Muñoz, Esther Carcelero, Ulrich Germing, Beate Betz, María Rozman, Leonor Arenillas, Lurdes Zamora, Maria Diez-Campelo, Blanca Xicoy, Jordi Esteve, Marina Díaz-Beyá
Journal: Blood
Blood (2023) 142 (Supplement 1): 3231.
https://doi.org/10.1182/blood-2023-173311
Published: 2023
Journal Articles

Description of Mutational Profile in Patients with Lower-Risk Myelodysplastic Syndromes at the Time of Leukemic Progression

Begoña Pedrote, Jose Francisco Falantes, Estrella Carrillo, Cristina Calderon-Cabrera, Francisco J Marquez-Malaver, Ildefonso Espigado, MD PhD, Jose A. Perez-Simon, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5301.
https://doi.org/10.1182/blood.V130.Suppl_1.5301.5301
Published: 2017
Journal Articles

Preliminary Results of the Flugaza Trial: A Phase III Randomized, Open Label Study Comparing Azacytidine Versus Fludarabine and Cytarabine (FLUGA Scheme) in Elderly Patients with Newly Diagnosed Acute Myeloid Leukemia

Pau Montesinos, MD PhD, Susana Vives, MD, Maria P Martinez-Sanchez, MD, Juan Bergua, MD, Lorenzo Algarra, MD, Herrera Pilar, MD, Mar Tormo, MD, Jose-Luis Lopez-Lorenzo, MD, Fernando Ramos, MD, Jose Francisco Falantes, MD, Olga Salamero, MD, Josefina Serrano, MD, Cristina Gil, MD, Maria L Amador, MD, Esperanza Lavilla, MD, Maria J Sayas, MD, Maria Teresa Olave, MD, Belen Vidriales, MD, David Martínez-Cuadrón, MD PhD, Miguel Ángel Sanz, MD PhD
Journal: Blood
Blood (2016) 128 (22): 4036.
https://doi.org/10.1182/blood.V128.22.4036.4036
Published: 2016
Journal Articles

Disease-Attributable Mortality in the Myelodysplastic Syndromes (MDS): A Study from the Spanish MDS Cooperative Group (GESMD)

Meritxell Nomdedeu, Xavier Calvo, Dolors Costa, Montserrat Arnan, MD PhD, Helena Pomares, MD, Guillermo Sanz, MD PhD, David Valcarcel, MD PhD, Elisa Luño, Fernando Ramos, Maria Diaz-Campelo, Rosa Collado, Raquel de Paz, Jose-Francisco Falantes, Carme Pedro, Jordi Esteve, Rafael Andreu, Maria-Teresa Ardanaz, Joaquin Sanchez-Garcia, Mar Tormo, MD PhD, Maria-Teresa Cedena, Beatriz Arrizabalaga, MD, Bernardo Gonzalez, Victor Marco, Salut Brunet, MD PhD, Arturo Pereira
Journal: Blood
Blood (2015) 126 (23): 1672.
https://doi.org/10.1182/blood.V126.23.1672.1672
Published: 2015
Journal Articles

Role of PET/CT Assesment before Autologous Stem Cell Transplantation in Relapsed or Refractory Lymphoma Patients

Fátima de la Cruz Vicente, MD, Maria Angeles Domiunguez Muñoz, MD, Estrella Carrillo Cruz, MD, José Francisco Márquez Malaver, Rocio Parody Porras, MD, Jose Francisco Falantes González, MD, Cristina Calderón Cabrera, MD, Olga Pérez López, MD, María Solé Rodríguez, MD, Jose González Campos, MD, María Isabel Montero Cuadrado, MD, María Luz Martino Galiana, MD, Jose Antonio Pérez-Simón, PhD, Ildefonso Espigado, PhD
Journal: Blood
Blood (2014) 124 (21): 3977.
https://doi.org/10.1182/blood.V124.21.3977.3977
Published: 2014
Journal Articles

Intensification of Chemotherapeutic Regimens and Hematopoietic Stem Cell Transplantation Are Responsible for Improved Overall Survival in Adult Acute Lymphoblastic Leukemia in a Single Center Over the Last Forty Years

Estrella Carrillo, MD, Nancy Rodriguez, Juan Francisco Dominguez, Jose Gonzalez, MD, Jose Francisco Falantes, MD, Isabel Montero, MD, M. Luz Martino, MD, Francisco Márquez-Malaver, Ricardo Parody, MD, Estefania Garcia-Guerrero, Jose Antonio Perez-Simón, Sr., MD, PhD, Ildefonso Espigado, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 4227.
https://doi.org/10.1182/blood.V118.21.4227.4227
Published: 2011
Journal Articles

Low-Intensity Fludarabine, Cyclophosphamyde, Rituximab (FCR) as Front-Line Treatment for Follicular Lymphoma. Efficacy and Toxicity Profile of the Oral Versus Intravenous Administration.

Ana Marin-Niebla, MD, Eduardo Rios-Herranz, MD, Fáatima de la Cruz Vicente, Jr., MD, Paula Cerezuela, MD, Jose Francisco Falantes, MD, Mariluz Martino, MD, Ildefonso Espigado, Alvaro Urbano Ispizua, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 2690.
https://doi.org/10.1182/blood.V114.22.2690.2690
Published: 2009